Why Some Patients Skip Daily CHG Baths After Stem Cell Transplants

Stem cell transplants, or HCT, offer hope to those fighting blood cancers. However, the intense treatment makes patients vulnerable to infections. These infections, known as HAI, are a big concern. One way to prevent them is through daily baths with a special soap called chlorhexidine gluconate, or CHG. But many patients aren't using it. Why is that? Let's explore the reasons. First, let's understand the problem. Despite standard precautions, bloodstream infections (BSI) are common among patients undergoing HCT. CHG baths can reduce these infections. But why aren't patients using it? One reason could be that patients aren't aware of the benefits. They might not know that CHG baths can lower the risk of infections. Another reason could be discomfort. The soap might cause skin irritation, making patients less likely to use it. To improve adherence, it's crucial to educate patients about CHG. They should know why it's important and how it can help. Also, addressing comfort issues can make a big difference. Maybe there are gentler soaps that work just as well. By understanding patients' perceptions and addressing their concerns, we can boost adherence to CHG baths. This could lead to better outcomes for patients undergoing HCT.